3 Space Stocks Flying Under the Radar and Worth Buying This Month

The key market dynamic is not that space has become expensive in absolute terms, but that the valuation dispersion is collapsing upward as investors increasingly treat the sector as an infrastructure compounder rather than a venture basket. That matters because the cheaper names are no longer the obvious rocket-beta trades; they are the picks-and-shovels providers with diversified end markets, which should command higher durability multiples, but also face slower multiple expansion from here as expectations normalize.

RDW looks best positioned on a second-order basis because defense exposure can subsidize space infrastructure optionality while reducing financing risk. The market is likely underestimating how much mission-critical components businesses benefit from a larger space capex cycle without needing a marquee launch franchise; this can create steadier order books and better downside protection than the headline space names. The main risk is that integration and margin execution remain the gating factor — if cross-sell synergies lag, the market may re-rate it as a mediocre defense supplier rather than a premium space platform.

SPIR is a cleaner balance-sheet repair story than a growth story, and that distinction matters over the next 12-24 months. If cash burn continues halving on schedule, the equity becomes a call option on reaching self-funding before liquidity forces dilution; if growth stalls before revenue re-accelerates, the path likely shifts back toward another capital raise. The market is probably overpaying for the turnaround narrative already, but underappreciating how much survivability improves when operating leverage turns even modestly positive.

ARXS is the most interesting contrarian because it is being priced like a broad industrial enabler with space upside, which can be justified only if space demand keeps compounding into a multi-year procurement cycle. The near-term risk is post-IPO supply and multiple compression: once forced buyers clear, any deceleration in aerospace/defense ordering could re-rate the stock lower even without fundamental deterioration. The better way to express the view may be relative value, since the upside from execution is likely more gradual than the current 9-10x sales multiple implies.